TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1829732

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (0.2%)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Stannous fluoride (0.2%)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 6872170

Group type: EXPERIMENTAL
Intervention: Propafenone (300 to 900 mg/day)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Propafenone (900 mg/day)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 13
Study: 30418157

Group type: EXPERIMENTAL
Intervention: Intracoronary tenecteplase
Number of subjects: 76

Group type: COMPARATOR
Intervention: Abciximab
Number of subjects: 76
Study: 28894292

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass
Number of subjects: 60

Group type: COMPARATOR
Intervention: Matched caloric restriction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vertical sleeve gastrectomy
Number of subjects: 60
Study: 25197789

Group type: EXPERIMENTAL
Intervention: Irregular utilisation of preschools
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Low parental socioeconomic status
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Age-adequate development of FM
Number of subjects: 599
Study: 25295403

Group type: EXPERIMENTAL
Intervention: Smart-Booking (algorithmically generated double-booking recommendations)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Control (usual booking rules)
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Smart-Booking
Number of subjects: 519

Group type: COMPARATOR
Intervention: Control
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Survey response from physicians after each session
Number of subjects: 519
Study: 23030574

Group type: EXPERIMENTAL
Intervention: Low literacy participants
Number of subjects: 975
Study: 20592632

Group type: EXPERIMENTAL
Intervention: Endoscopic lacrimal duct recanalization (ELDR)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard external dacryocystorhinostomy (SE‐DCR)
Number of subjects: 166
Study: 17882923

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450

Group type: COMPARATOR
Intervention: Mometasone nasal spray
Number of subjects: 450
Study: 16280286

Group type: EXPERIMENTAL
Intervention: Irbesartan/HCTZ (150/12.5 mg)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Valsartan/HCTZ (80/12.5 mg)
Number of subjects: 800
Study: 11988719

Group type: EXPERIMENTAL
Intervention: Arthroscopic acromioplasty
Number of subjects: 62

Group type: COMPARATOR
Intervention: Open acromioplasty
Number of subjects: 62
Study: 10465817

Group type: EXPERIMENTAL
Intervention: Structured 14-day quit programme (Time to quit)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Another booklet describing four broad stages of quitting (Can quit)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Both groups (Time to quit and Can quit)
Number of subjects: 521
Study: 7604803

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg/day
Number of subjects: 1810

Group type: EXPERIMENTAL
Intervention: Fluvastatin + cholestyramine
Number of subjects: 1810

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1810
Study: 2211130

Group type: EXPERIMENTAL
Intervention: Group Health Cooperative of Puget Sound
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparable fee‐for‐service insurance plans
Number of subjects: 0
Study: 681061

Group type: EXPERIMENTAL
Intervention: Family practice nurse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 0
Study: 31195650

Group type: EXPERIMENTAL
Intervention: Remote device-monitoring system (TM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard outpatient visits (HM)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (TM and HM)
Number of subjects: 50
Study: 28407625

Group type: EXPERIMENTAL
Intervention: Mapracorat 0.1% ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reference drugs
Number of subjects: 0
Study: 25820660

Group type: EXPERIMENTAL
Intervention: Self-compassion training (N = 13)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Stress inoculation training (N = 14)
Number of subjects: 47
Study: 23958776

Group type: EXPERIMENTAL
Intervention: Universal ultrasound screening
Number of subjects: 2011

Group type: EXPERIMENTAL
Intervention: Selective ultrasound screening
Number of subjects: 2011

Group type: COMPARATOR
Intervention: Clinical examination (control group)
Number of subjects: 2011
Study: 21606094

Group type: EXPERIMENTAL
Intervention: Patient navigation-based intervention
Number of subjects: 465

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Patient navigation-based intervention (non-English speakers)
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Patient navigation-based intervention (black patients)
Number of subjects: 465
Study: 19780001

Group type: EXPERIMENTAL
Intervention: Botulinum toxin‐A injection (25 U, 0.5 ml, once)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lidocaine injection (2 ml, 20 mg, 1% lidocaine, twice a week for one month)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation (TENS, 60 sessions)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laser treatments (20 sessions)
Number of subjects: 100
Study: 16122963

Group type: EXPERIMENTAL
Intervention: Lempel-Ziv complexity (two-symbol sequence conversion)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Lempel-Ziv complexity (three-symbol sequence conversion)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Central tendency measure (CTM)
Number of subjects: 11
Study: 15349707

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 4

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg
Number of subjects: 4

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg
Number of subjects: 4

Group type: COMPARATOR
Intervention: Rabeprazole 20 mg
Number of subjects: 4

Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 4
Study: 11565402

Group type: EXPERIMENTAL
Intervention: Magnet-on group (active treatment)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Magnet-off group (placebo control)
Number of subjects: 176
Study: 9022871

Group type: EXPERIMENTAL
Intervention: Familiar drink (beer)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Unfamiliar drink (blue peppermint mixture)
Number of subjects: 2
Study: 8179847

Group type: EXPERIMENTAL
Intervention: Head out of water immersion (HOI) for 2 hours
Number of subjects: 27
Study: 3299763

Group type: EXPERIMENTAL
Intervention: Whole theophylline tablets (Euphyllin Retard)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Halved theophylline tablets (Euphyllin Retard)
Number of subjects: 14
Study: 31223099

Group type: EXPERIMENTAL
Intervention: Fast infusion (1 h) of Zn (100 μmol)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Slow infusion (10 h) of Zn (100 μmol)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fast infusion (1 h) of Mn (1000 nmol)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Slow infusion (10 h) of Mn (1000 nmol)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fast infusion (1 h) of Se (1 μmol)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Slow infusion (10 h) of Se (1 μmol)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fast infusion (1 h) of Cr (200 nmol)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Slow infusion (10 h) of Cr (200 nmol)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fast infusion (1 h) of Cu (8 μmol)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Slow infusion (10 h) of Cu (8 μmol)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fast infusion (1 h) of Fe (20 μmol)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Slow infusion (10 h) of Fe (20 μmol)
Number of subjects: 39
Study: 29880231

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks for up to 2 years
Number of subjects: 592

Group type: COMPARATOR
Intervention: Paclitaxel (standard-dose)
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 592

Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 592
Study: 26857909

Group type: EXPERIMENTAL
Intervention: Pulmonary vein antral isolation (PVAI) in sinus rhythm after direct current cardioversion
Number of subjects: 90

Group type: COMPARATOR
Intervention: PVAI and ablation targeting complex-fractionated atrial electrograms while in AF
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group 1 ablation
Number of subjects: 90
Study: 25100336

Group type: EXPERIMENTAL
Intervention: 80 kVp, 2.2 pitch, 20 ml of contrast medium and sinogram affirmed iterative reconstruction
Number of subjects: 100

Group type: COMPARATOR
Intervention: 100 kVp, 1.2 pitch, 60 ml of contrast medium and filtered back projection algorithm
Number of subjects: 100
Study: 22093187

Group type: EXPERIMENTAL
Intervention: Denosumab 120 mg subcutaneously every 4 weeks
Number of subjects: 1432

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1432
Study: 20818194

Group type: EXPERIMENTAL
Intervention: lower limb exercise (HEEL)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: compression garment (TROU)
Number of subjects: 6

Group type: COMPARATOR
Intervention: no intervention (CONTROL)
Number of subjects: 6
Study: 17375862

Group type: EXPERIMENTAL
Intervention: Chronic disease management models for depression in primary care
Number of subjects: 0
Study: 15266171

Group type: EXPERIMENTAL
Intervention: 99mTc tetrofosmin scintigraphy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (37 patients without bone marrow pathology)
Number of subjects: 27
Study: 10812854

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (bladder training and pelvic floor muscle training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (bladder training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (pelvic floor muscle training)
Number of subjects: 0
Study: 9113175

Group type: EXPERIMENTAL
Intervention: bupivacaine 12.5 mg + 10 micrograms fentanyl subarachnoidally
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: bupivacaine 12.5 mg + saline subarachnoidally
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: bupivacaine 100 mg + 100 micrograms fentanyl epidurally
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: bupivacaine 100 mg + saline epidurally
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (saline) subarachnoidally
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (saline) epidurally
Number of subjects: 100
Study: 1350428

Group type: EXPERIMENTAL
Intervention: Vitamin E (1600 IU/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 3928213

Group type: EXPERIMENTAL
Intervention: Simultaneous TRH/domperidone administration
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: TRH administration at 120 min during domperidone infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Domperidone administered at 120 min during TRH infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: TRH administered at 120 min during TRH infusion
Number of subjects: 6
Study: 3301785

Group type: EXPERIMENTAL
Intervention: Colistin inhalation (1 million units twice daily for three months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo inhalation (isotonic saline)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Colistin inhalation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo inhalation
Number of subjects: 40
Study: 30984320

Group type: EXPERIMENTAL
Intervention: Occlusal appliance (OA) with nonsteroidal anti‐inflammatory drug (NSAID) therapy (nimesulide)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Occlusal appliance with dry needling (DN)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Occlusal appliance (OA-control group)
Number of subjects: 90
Study: 29136001

Group type: EXPERIMENTAL
Intervention: Combination Intervention Strategy (CIS)
Number of subjects: 2004

Group type: EXPERIMENTAL
Intervention: CIS+ (enhanced CIS with financial incentives)
Number of subjects: 2004

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 2004
Study: 26113687

Group type: EXPERIMENTAL
Intervention: Bosentan (125 mg twice daily)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study: 23145999

Group type: EXPERIMENTAL
Intervention: LF-PSu dialyzer
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: HF-PSu dialyzer
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: PUR-H dialyzer
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Maintenance hemodialysis patients
Number of subjects: 170

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 170
Study: 21552185

Group type: EXPERIMENTAL
Intervention: ART deferred until CD4 < 25% or severe HIV disease (group 1, n = 20)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: ART initiation within 6 to 12 weeks of age (group 2, n = 34)
Number of subjects: 54

Group type: COMPARATOR
Intervention: HIV-exposed uninfected infants (controls, n = 22)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: All HIV-infected infants with ART
Number of subjects: 54
Study: 18077134

Group type: EXPERIMENTAL
Intervention: 15 mg/d of supplemental Zn
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 30 mg/d of supplemental Zn
Number of subjects: 48

Group type: COMPARATOR
Intervention: 0 mg/d of supplemental Zn (placebo)
Number of subjects: 48
Study: 17060762

Group type: EXPERIMENTAL
Intervention: Negative pressure closure (NPC) dressing connected to central aspiration system at -80 mm Hg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with similar dressing but without connection to negative pressure
Number of subjects: 60
Study: 15364188

Group type: EXPERIMENTAL
Intervention: Participatory intervention with women's groups
Number of subjects: 28931

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28931
Study: 11011299

Group type: EXPERIMENTAL
Intervention: Mammographic screening in women with a family history of breast cancer
Number of subjects: 29179
Study: 9292842

Group type: EXPERIMENTAL
Intervention: Automated, guideline-based reminders for corollary orders
Number of subjects: 89

Group type: COMPARATOR
Intervention: No reminders about corollary orders (Control)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 89
Study: 8357194

Group type: EXPERIMENTAL
Intervention: Cyclosporine (5 mg/kg per body weight in divided doses)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 39
Study: 3094562

Group type: EXPERIMENTAL
Intervention: medrysone (1%)
Number of subjects: 38

Group type: COMPARATOR
Intervention: sodium cromoglycate (2%)
Number of subjects: 38
Study: 30158221

Group type: EXPERIMENTAL
Intervention: Three-year universal school-based resilience intervention targeting student resilience protective factors (2012-2014)
Number of subjects: 3155

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 3155
Study: 27912933

Group type: EXPERIMENTAL
Intervention: Healing Meditation (n=20), 8-week program, 1 hour weekly meetings
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (waiting list, n=21)
Number of subjects: 41
Study: 22956670

Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 23900047

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 18264
Study: 20413966

Group type: EXPERIMENTAL
Intervention: Diet/training program
Number of subjects: 28
Study: 18424598

Group type: EXPERIMENTAL
Intervention: 100 g of pureed strawberries (15 micromol anthocyanin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 200 g of pureed strawberries (30 micromol anthocyanin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 g of pureed strawberries (60 micromol anthocyanin)
Number of subjects: 12
Study: 16623404

Group type: EXPERIMENTAL
Intervention: Closed-circuit anesthesia (CCA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Semiclosed anesthesia (SCA)
Number of subjects: 27
Study: 12803261

Group type: EXPERIMENTAL
Intervention: Bispectral index monitoring
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no bispectral index monitoring visible to anaesthesiologist)
Number of subjects: 30
Study: 10910870

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (4 microg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (saline injection)
Number of subjects: 12
Study: 8807692

Group type: EXPERIMENTAL
Intervention: Assertive community rehabilitation program
Number of subjects: 110

Group type: COMPARATOR
Intervention: Hospital-based rehabilitation programs
Number of subjects: 110
Study: 1314871

Group type: EXPERIMENTAL
Intervention: Live attenuated varicella vaccine
Number of subjects: 0
Study: 3902184

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride 100 mg twice a day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 30629589

Group type: EXPERIMENTAL
Intervention: Random Forest Classifier
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Decision Tree Classifier focusing on lung side and platelet count
Number of subjects: 324
Study: 30106883

Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/d for 4 weeks, then flexible dose up to 200 mg/d if needed.
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 77
Study: 26987056

Group type: EXPERIMENTAL
Intervention: Intervention follow‐on formula (IF, 2.1g isomaltulose (Palatinose™)/100mL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isocaloric conventional formula (CF, providing 2.1g maltodextrin/100mL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intervention follow‐on formula (IF)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isocaloric conventional formula (CF)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both formulae
Number of subjects: 50
Study: 24104542

Group type: EXPERIMENTAL
Intervention: Normal frequency breathing with fins (F)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal frequency breathing without fins (S)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Complete apnea with fins (FAp)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Complete apnea without fins (SAp)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Saliva dehydroepiandrosterone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Saliva cortisol and testosterone
Number of subjects: 15
Study: 21553010

Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 0
Study: 19624401

Group type: EXPERIMENTAL
Intervention: Nutritional care interventions (specific interventions not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nutritional screening
Number of subjects: 0
Study: 18004127

Group type: EXPERIMENTAL
Intervention: Sertraline (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15209786

Group type: EXPERIMENTAL
Intervention: Flashlamp-pulsed dye laser treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Different flashlamp-pulsed dye laser settings
Number of subjects: 0
Study: 11438914

Group type: EXPERIMENTAL
Intervention: Clarithromycin, 15 mg/kg/day orally in 2 divided doses for 7 days
Number of subjects: 51

Group type: COMPARATOR
Intervention: Chloramphenicol, 50 mg/kg/day orally in 4 divided doses for 7 days
Number of subjects: 51
Study: 9580263

Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP) - bolus injections of 3, 6 and 9 mg/5 min
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isoproterenol - bolus injections of 2, 4 and 6 micrograms/5 min
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (normal subjects) - adenosine in the upright position
Number of subjects: 30
Study: 7851367

Group type: EXPERIMENTAL
Intervention: Exercise group (E)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Non-exercise group (NE)
Number of subjects: 62
Study: 3132866

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.8 mg/70 kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31975352

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 974

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 974
Study: 30450689

Group type: EXPERIMENTAL
Intervention: Mastiha (2.8 g/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 28586537

Group type: EXPERIMENTAL
Intervention: Vericiguat 10 mg once daily
Number of subjects: 477

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 477
Study: 27032739

Group type: EXPERIMENTAL
Intervention: IVPCA with fentanyl
Number of subjects: 37

Group type: COMPARATOR
Intervention: PCEA with bupivacaine and fentanyl
Number of subjects: 37
Study: 24559855

Group type: EXPERIMENTAL
Intervention: Phospholipid milk (3g phospholipids, 0.75g sphingomyelin)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control milk (normal whole milk)
Number of subjects: 39
Study: 22588692

Group type: EXPERIMENTAL
Intervention: Open-field surgical carpal tunnel release followed by longitudinal epineurotomy of the nerve (test)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open-field release without epineurotomy (control)
Number of subjects: 50
Study: 19509121

Group type: EXPERIMENTAL
Intervention: 5 years of bisphosphonate treatment
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: 10 years of bisphosphonate treatment
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: 2000 to 5000 participants per arm
Number of subjects: 2000
Study: 17215185

Group type: EXPERIMENTAL
Intervention: 200,000 IU of Vitamin A
Number of subjects: 613

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 613
Study: 14712422

Group type: EXPERIMENTAL
Intervention: Steroids and cyclosporine (group 1)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Steroids and chlorambucil (group 2)
Number of subjects: 57
Study: 12136499

Group type: EXPERIMENTAL
Intervention: Appearance-focused intervention (short workbook on appearance damaging effects of indoor tanning)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Appearance-focused intervention
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 147